| 000 | 01126 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514180606.0 | ||
| 264 | 0 | _c20040430 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1381-6128 | ||
| 024 | 7 |
_a10.2174/1381612043453306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDery, J P | |
| 245 | 0 | 0 |
_aGP IIb/IIIa blockade in elective percutaneous coronary intervention. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2004 |
||
| 300 |
_a387-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 700 | 1 | _aHarrington, R A | |
| 700 | 1 | _aTcheng, J E | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 10 _gno. 4 _gp. 387-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612043453306 _zAvailable from publisher's website |
| 999 |
_c14687802 _d14687802 |
||